Previous close | 37.23 |
Open | 37.62 |
Bid | 37.48 x 300 |
Ask | 37.64 x 300 |
Day's range | 37.22 - 37.79 |
52-week range | 27.13 - 50.92 |
Volume | |
Avg. volume | 2,374,151 |
Market cap | 13.378B |
Beta (5Y monthly) | 1.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.40 (3.76%) |
Ex-dividend date | 16 Aug 2024 |
1y target est | N/A |
Todd Stottlemyer, Acentra Health CEO Acentra Health CEO Todd Stottlemyer named to Virginia's most influential leaders list by Virginia Business Magazine. MCLEAN, Va., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for government healthcare agencies and the priority populations they serve, announced today that Virginia Business Magazine has named CEO Todd Stottlemyer to its 2024 Virginia 500 Power
Management provides view on recently announced Vantive-Carlyle Group transactionTORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shoc
Recognition highlights Acentra Health’s growth and role as a vital partner to its growing roster of public health sector clientsMCLEAN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to helping government healthcare agencies accelerate better outcomes for their priority populations, has been named to the Washington Business Journal’s “Fastest Growing Companies” list, which highlights private companies in the Washington, D.C